11.79
price up icon0.51%   0.06
 
loading
Precedente Chiudi:
$11.73
Aprire:
$11.81
Volume 24 ore:
1.47M
Relative Volume:
0.71
Capitalizzazione di mercato:
$1.05B
Reddito:
$2.35B
Utile/perdita netta:
$-74.42M
Rapporto P/E:
-12.54
EPS:
-0.94
Flusso di cassa netto:
$150.93M
1 W Prestazione:
+9.67%
1M Prestazione:
+37.89%
6M Prestazione:
-0.76%
1 anno Prestazione:
-40.27%
Intervallo 1D:
Value
$11.61
$11.92
Intervallo di 1 settimana:
Value
$10.54
$11.92
Portata 52W:
Value
$7.06
$33.48

Evolent Health Inc Stock (EVH) Company Profile

Name
Nome
Evolent Health Inc
Name
Telefono
571-389-6000
Name
Indirizzo
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Name
Dipendente
4,500
Name
Cinguettio
@EvolentHealth
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
EVH's Discussions on Twitter

Confronta EVH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Health Information Services icon
EVH
Evolent Health Inc
11.79 1.05B 2.35B -74.42M 150.93M -0.94
Health Information Services icon
VEEV
Veeva Systems Inc
284.29 46.43B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
60.97 12.01B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
61.69 10.79B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
102.16 9.27B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
39.34 7.03B 906.14M -52.62M 89.62M -0.3621

Evolent Health Inc Stock (EVH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-10 Iniziato Needham Buy
2024-12-03 Reiterato BTIG Research Buy
2024-11-08 Downgrade Stephens Overweight → Equal-Weight
2024-10-11 Iniziato KeyBanc Capital Markets Overweight
2024-08-09 Aggiornamento Truist Hold → Buy
2024-04-22 Iniziato Citigroup Buy
2024-03-01 Iniziato Oppenheimer Outperform
2024-01-03 Iniziato Barclays Overweight
2023-12-06 Iniziato JMP Securities Mkt Outperform
2023-10-16 Iniziato UBS Buy
2023-04-12 Iniziato Stephens Overweight
2022-11-01 Iniziato Truist Hold
2022-07-29 Iniziato RBC Capital Mkts Outperform
2022-03-30 Iniziato Guggenheim Buy
2021-11-18 Aggiornamento JP Morgan Neutral → Overweight
2021-04-29 Ripresa JP Morgan Neutral
2021-01-07 Iniziato BTIG Research Buy
2020-07-06 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2020-06-05 Downgrade Goldman Buy → Neutral
2020-06-02 Downgrade Cantor Fitzgerald Overweight → Neutral
2018-10-05 Ripresa Leerink Partners Outperform
2018-06-04 Iniziato Piper Jaffray Overweight
2018-04-24 Ripresa JP Morgan Neutral
2017-09-20 Iniziato KeyBanc Capital Mkts Overweight
2017-06-02 Iniziato Robert W. Baird Outperform
2017-03-14 Iniziato Oppenheimer Outperform
2017-01-13 Aggiornamento Wells Fargo Market Perform → Outperform
2016-10-28 Ripresa JP Morgan Overweight
2016-08-05 Reiterato FBR Capital Outperform
2016-07-26 Iniziato Jefferies Buy
2016-07-13 Reiterato FBR Capital Outperform
2016-03-29 Iniziato FBR Capital Outperform
2016-01-06 Iniziato Canaccord Genuity Buy
2015-06-30 Iniziato Goldman Buy
2015-06-30 Iniziato JP Morgan Overweight
2015-06-30 Iniziato Leerink Partners Outperform
2015-06-30 Iniziato Sun Trust Rbsn Humphrey Buy
Mostra tutto

Evolent Health Inc Borsa (EVH) Ultime notizie

pulisher
Jun 10, 2025

EVH Q1 Earnings Call: Oncology Navigation Launch and AI Automation Drive Strategic Focus - Yahoo Finance

Jun 10, 2025
pulisher
Jun 05, 2025

Evolent Health, Inc. Appoints Shawn Guertin to the Board of Directors and Reconstitutes Compositions of Committees, Effective June 5, 2025 - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

3 Stocks Under $10 in the Doghouse - Yahoo Finance

Jun 05, 2025
pulisher
Jun 05, 2025

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Evolent Health, Inc. To Contact The Firm - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 03, 2025

Evolent Health at William Blair Conference: Strategic Growth Amid Challenges - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Evolent Health Reaffirms 2025 Revenue and EBITDA Guidance - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Evolent HealthReaffirms 2025 Revenue Guidance Of $2.06 Bln To $2.11 BlnSEC Filing - marketscreener.com

Jun 03, 2025
pulisher
May 30, 2025

Why Investors Shouldn't Be Surprised By Evolent Health, Inc.'s (NYSE:EVH) 25% Share Price Plunge - simplywall.st

May 30, 2025
pulisher
May 27, 2025

Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know - Yahoo Finance

May 27, 2025
pulisher
May 26, 2025

Evolent Health’s SWOT analysis: value-based care provider faces challenges, opportunities - Investing.com Australia

May 26, 2025
pulisher
May 25, 2025

Evolent Health’s SWOT analysis: value-based care provider faces challenges, opportunities By Investing.com - Investing.com South Africa

May 25, 2025
pulisher
May 25, 2025

Evolent Health, Inc. (NYSE:EVH) Given Average Recommendation of “Buy” by Analysts - Defense World

May 25, 2025
pulisher
May 23, 2025

Deutsche Bank AG Raises Holdings in Evolent Health, Inc. (NYSE:EVH) - Defense World

May 23, 2025
pulisher
May 22, 2025

Trend Tracker for (EVH) - news.stocktradersdaily.com

May 22, 2025
pulisher
May 21, 2025

Reflecting On Healthcare Technology for Providers Stocks’ Q1 Earnings: Evolent Health (NYSE:EVH) - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

Evolent Health stock hits 52-week low at $8.35 By Investing.com - Investing.com South Africa

May 21, 2025
pulisher
May 21, 2025

Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know - Yahoo Finance

May 21, 2025
pulisher
May 21, 2025

Evolent Health stock hits 52-week low at $8.35 - Investing.com Australia

May 21, 2025
pulisher
May 19, 2025

Comerica Bank Has $69,000 Holdings in Evolent Health, Inc. (NYSE:EVH) - Defense World

May 19, 2025
pulisher
May 15, 2025

Needham & Company LLC Reiterates Buy Rating for Evolent Health (NYSE:EVH) - Defense World

May 15, 2025
pulisher
May 13, 2025

Evolent Health (EVH) Sees Analyst Reaffirm Buy Rating and $15 Pr - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Evolent Health (EVH) Sees Analyst Reaffirm Buy Rating and $15 Price Target | EVH Stock News - GuruFocus

May 13, 2025
pulisher
May 12, 2025

Evolent Health (NYSE:EVH) Price Target Raised to $15.00 - Defense World

May 12, 2025
pulisher
May 11, 2025

Evolent Health (NYSE:EVH shareholders incur further losses as stock declines 15% this week, taking three-year losses to 68% - simplywall.st

May 11, 2025
pulisher
May 10, 2025

Evolent Health (EVH) Receives Price Target Upgrade from UBS | EV - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Evolent Health, Inc. (NYSE:EVH) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 10, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evolent Health (EVH), Verastem (VSTM) and Sight Sciences (SGHT) - The Globe and Mail

May 10, 2025
pulisher
May 09, 2025

Evolent Health Inc. Earnings Call Highlights Growth and Expansion - TipRanks

May 09, 2025
pulisher
May 09, 2025

Expert Outlook: Evolent Health Through The Eyes Of 9 Analysts - Benzinga

May 09, 2025
pulisher
May 09, 2025

Evolent Health (EVH) Receives Price Target Upgrade from UBS | EVH Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Evolent Health Q1 2025 slides: Revenue falls but company maintains full-year guidance - Investing.com Australia

May 09, 2025
pulisher
May 09, 2025

UBS Adjusts Price Target on Evolent Health to $15 From $14, Maintains Buy Rating - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Evolent Health (EVH) Receives Price Target Boost from UBS | EVH Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Evolent Health Surpasses Revenue Expectations Despite Sales Decline - IndexBox

May 09, 2025
pulisher
May 09, 2025

Evolent Health Inc earnings missed by $0.02, revenue topped estimates - Investing.com India

May 09, 2025
pulisher
May 09, 2025

Evolent Health, Inc. SEC 10-Q Report - TradingView

May 09, 2025
pulisher
May 09, 2025

Evolent Health Inc (EVH) Q1 2025 Earnings Call Highlights: Strong Start with New Agreements and ... By GuruFocus - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Evolent Health Inc (EVH) Q1 2025 Earnings Call Highlights: Strong Start with New Agreements and ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Evolent Health Inc (EVH) Q1 2025 Earnings Call Highlights: Strong Start with New Agreements and AI Advancements - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Earnings call transcript: Evolent Health Q1 2025 misses EPS forecast, stock rises - Investing.com

May 09, 2025
pulisher
May 09, 2025

Evolent Health: Q1 Earnings Snapshot - Norwalk Hour

May 09, 2025
pulisher
May 09, 2025

Evolent Health Reports Strong Q1 2025 Growth - TipRanks

May 09, 2025
pulisher
May 08, 2025

Evolent Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 08, 2025
pulisher
May 08, 2025

Evolent Health (EVH) Q1 Earnings Lag Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Evolent Health (NYSE:EVH) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance

May 08, 2025

Evolent Health Inc Azioni (EVH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Evolent Health Inc Azioni (EVH) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
McCarthy Daniel Joseph
PRESIDENT
Mar 06 '25
Buy
9.01
11,040
99,470
389,004
Jelinek Richard M
Director
Mar 07 '25
Buy
9.12
30,000
273,750
15,000
GRUA PETER J
Director
Mar 06 '25
Buy
9.01
11,040
99,470
18,749
Blackley Seth
Chief Executive Officer
Mar 06 '25
Buy
9.01
55,225
497,577
762,217
Springstubb Brendan B
Director
Mar 07 '25
Buy
9.27
15,000
139,050
26,842
Glass Russell Monroe
Director
Mar 06 '25
Buy
9.27
5,400
50,058
14,272
KECK KIM
Director
Mar 07 '25
Buy
9.44
10,540
99,498
39,522
Barbarosh Craig A.
Director
Mar 06 '25
Buy
8.81
2,000
17,620
31,956
Springstubb Brendan B
Director
Mar 04 '25
Buy
8.75
5,000
43,750
11,842
$21.12
price up icon 0.76%
$11.33
price down icon 1.39%
$22.11
price up icon 0.87%
$46.63
price up icon 4.53%
$22.12
price up icon 0.55%
health_information_services WAY
$39.34
price up icon 1.73%
Capitalizzazione:     |  Volume (24 ore):